Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm.

Allergy

Aix-Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée Infection, Marseille, France.

Published: November 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1111/all.15299DOI Listing

Publication Analysis

Top Keywords

aspergillus fumigatus
4
fumigatus personalized
4
personalized medicine
4
medicine clinically
4
clinically reliable
4
reliable algorithm
4
aspergillus
1
personalized
1
medicine
1
clinically
1

Similar Publications

The structural role of β-1,6-glucan has remained under-investigated in filamentous fungi compared to other fungal cell wall polymers, and previous studies have shown that the cell wall of the mycelium of did not contain β-1,6-glucans. In contrast, the current solid-state NMR investigations showed that the conidial cell wall contained a low amount of β-1,6-glucan. ssNMR comparisons of the and β-1,6-glucans showed they are structurally similar.

View Article and Find Full Text PDF

Antifungal activity of cinnamaldehyde against involves disruption of the TCA cycle and protein metabolism.

Front Microbiol

August 2025

Department of Medical Laboratory Diagnostics, School of Medical Technology, Shaoyang University, Shaoyang, China.

is an environmental opportunistic fungal pathogen, which can lead to invasive aspergillosis in immunocompromised individuals, and resistant to conventional antifungual agents has become a growing concern. This study investigated the antifungal activity and the molecular antifungal mechanisms of Cinnamaldehyde (CA) against , specifically its impact on metabolic pathways and protein metabolism. In susceptibility tests, CA was found to exhibit promising antifungal activity against in both solid and liquid culture (biomass) systems, with the minimum inhibitory concentration (MIC) determined as 40-80 μg/mL.

View Article and Find Full Text PDF

The effects of climatic variability on the occurrence of Aspergillus species in commercial maize from different agro-climatic regions in South Africa.

Fungal Biol

October 2025

Food Security and Safety Focus Area, Faculty of Natural and Agricultural Sciences, North-West University, Private Bag X2046, Mmabatho, 2735, South Africa; Department of Animal Health, Faculty of Natural and Agricultural Sciences, North-West University, Private Bag X2046, Mmabatho, 2735, South Africa

Most African research reports on the frequent aflatoxin contamination of various foodstuffs, with few reports giving details of the Aspergillus species present in these commodities. Numerous research works provide evidence of the ability of fungi to grow, thrive, and interact with other crop species and focus on the fact that these processes are largely affected by climatic variables. As opposed to the attention directed to the above-mentioned themes, information on the biodiversity of Aspergillus species in maize in most African countries, including South Africa, is lacking.

View Article and Find Full Text PDF

Forty years of global research on WHO's four critical priority fungal pathogens: Advances and prospects.

J Infect Public Health

August 2025

Infection Control Center, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China; National Clinical Research Center for Geriatric Disorders (XiangYa Hospital), Changsha, Hunan Province 410008, China; Superbugs and Multidrug Resistant Microbes Infection Control Research Ce

Background: On October 25, 2022, the World Health Organization (WHO) released its first Fungal Priority Pathogen List (FPPL), classifying Cryptococcus neoformans (C. neoformans), Candida auris (C. auris), Aspergillus fumigatus (A.

View Article and Find Full Text PDF

Aspergillus and Host-Pathogen Interaction: Focus on treatment-relevant aspects.

Clin Microbiol Infect

September 2025

Institut Pasteur, Université Paris Cité, Immunologie des Infections Fongiques, Paris, France; Laboratoire de Parasitologie-Mycologie, AP-HP, Hôpital Saint-Louis, Paris, France. Electronic address:

Background: Invasive aspergillosis (IA) remains a major cause of morbidity and mortality in immunocompromised individuals, with an expanding spectrum of at-risk populations, particularly in the intensive care settings. Despite advances in antifungal pharmacotherapy, treatment outcomes remain suboptimal, and the rise of antifungal resistance highlights the need for adjunctive therapy that leverage host immune mechanisms. The pathogenesis of IA is primarily driven by impaired or dysregulated immune responses to Aspergillus species, mainly Aspergillus fumigatus.

View Article and Find Full Text PDF